{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2016-30399:v1","objectPathId":"federal-register-2016-30399-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2016-30399/","json":"https://peptidescanner.com/evidence/v1/objects/federal-register-2016-30399-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/federal-register-2016-30399-v1.md"},"story":{"slug":"federal-register-2016-30399","version":1,"domain":"Regulatory","dateInSource":"2016-12-19","sourceCheckedAt":"2026-08-21","publishedAt":"2026-08-21","peptideSlugs":["dulaglutide"],"peptides":[{"slug":"dulaglutide","url":"https://peptidescanner.com/peptides/dulaglutide/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2016-30399","sourceIds":["federal-register-2016-30399-a3b4e20b5382"]},{"id":"summary","text":"The Federal Register published notice 2016-30399, attributed to FDA and its parent HHS department, on 2016-12-19. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY,” and PeptideScanner's exact reviewed identity mapping connects the document to Dulaglutide.","sourceIds":["federal-register-2016-30399-a3b4e20b5382"]},{"id":"paragraph-1","text":"The Federal Register published notice 2016-30399, attributed to FDA and its parent HHS department, on 2016-12-19. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY,” and PeptideScanner's exact reviewed identity mapping connects the document to Dulaglutide.","sourceIds":["federal-register-2016-30399-a3b4e20b5382"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2016-30399-a3b4e20b5382"]}],"sources":[{"id":"federal-register-2016-30399-a3b4e20b5382","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2016-30399 · published 2016-12-19 · Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY","url":"https://www.govinfo.gov/content/pkg/FR-2016-12-19/pdf/2016-30399.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"662da06ed407b784c1465fd2e0ad03730ae3b39a30b7284b64ebd629e4f040b4","tierARecordSha256":"a3b4e20b53821aa2e7c280ab26b40f60f6bdff6b1fb718ced75d07e36a2aa191"},"integrity":{"algorithm":"sha256","contentSha256":"926afdc24d37d69d2e04fbeed5ab7a916e0a90b959cc3ec8136dce4b1cc80d4e"}}